Diazepan derivatives
US7632829B2 · kind B2 · utility
2Cited by
0References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 19, 2007 |
| Grant date | Dec 15, 2009 |
| Priority date | — |
| Expiry date | Oct 3, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is concerned with novel diazepan derivatives of formula (I)wherein A, X, R3, R4, R5, R6, R8, R9, R10, R11, R12, R13, m and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR-2 receptor, CCR-5 receptor and/or CCR-3 receptor and can be used as medicaments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.